CorMedix Inc. 4

4 · CorMedix Inc. · Filed Aug 16, 2016

Form 4

Period: 2016-08-12

Director

Transactions

Award
Phantom Stock
2016-08-12+4,335→ 4,335 total
Exercise: $0.00→ Common Stock (4,335 underlying)

Holdings

Stock Option (Right to buy Common Stock)
Exercise: $2.11Exp: 2024-04-05→ Common Stock (15,000 underlying)
15,000
Stock Option (Right to buy Common Stock)
Exercise: $2.79Exp: 2024-02-27→ Common Stock (30,000 underlying)
30,000
Phantom Stock
Exercise: $0.00→ Common Stock (3,968 underlying)
3,968
Phantom Stock
Exercise: $0.00→ Common Stock (1,847 underlying)
1,847
Phantom Stock
Exercise: $0.00→ Common Stock (3,125 underlying)
3,125
Stock Option (Right to buy Common Stock)
Exercise: $1.91Exp: 2026-02-21→ Common Stock (90,000 underlying)
90,000
Phantom Stock
Exercise: $0.00→ Common Stock (2,767 underlying)
2,767
Stock Option (Right to buy Common Stock)
Exercise: $5.62Exp: 2025-03-01→ Common Stock (50,000 underlying)
50,000
Phantom Stock
Exercise: $0.00→ Common Stock (1,176 underlying)
1,176
Phantom Stock
Exercise: $0.00→ Common Stock (2,459 underlying)
2,459

Footnotes (4)

[F1]5,000 vest upon completion of an April 2014 milestone; 10,000 vest upon completion of another milestone by the third quarter of 2014.
[F2]These options vest in full on the first anniversary of the date of grant.
[F3]Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
[F4]These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of director fees.

Documents

1 file